| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2005/09/30 | 07 : 27 | PR Newswire (US) | Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/09/01 | 20 : 00 | Business Wire | MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/08/08 | 23 : 11 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2005 Second Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/08/08 | 21 : 45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/08/03 | 03 : 33 | PR Newswire (US) | Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/25 | 04 : 44 | PR Newswire (US) | Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/19 | 04 : 00 | PR Newswire (US) | Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/18 | 04 : 39 | PR Newswire (US) | Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/12 | 00 : 01 | PR Newswire (US) | AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/09 | 22 : 42 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2005 First Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/09 | 21 : 45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/05/02 | 22 : 00 | PR Newswire (US) | Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/04/22 | 03 : 07 | PR Newswire (US) | Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/04/06 | 21 : 45 | PR Newswire (US) | Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/04/06 | 02 : 31 | PR Newswire (US) | Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/03/25 | 02 : 04 | PR Newswire (US) | Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary Endpoint | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/03/09 | 01 : 03 | PR Newswire (US) | Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/03/02 | 05 : 55 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2004 Year-End Financial Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/03/01 | 21 : 45 | PR Newswire (US) | Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2005/02/11 | 01 : 42 | PR Newswire (US) | Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/12/18 | 07 : 30 | PR Newswire (US) | Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net Proceeds | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/12/02 | 22 : 45 | PR Newswire (US) | Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) Pro | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/22 | 23 : 03 | PR Newswire (US) | Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/18 | 07 : 30 | PR Newswire (US) | Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ Rules | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/17 | 22 : 01 | PR Newswire (US) | Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford Pharmaceuticals | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/13 | 00 : 58 | PR Newswire (US) | AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual Meeting | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/09 | 02 : 11 | PR Newswire (US) | Guilford Pharmaceuticals Reports 2004 Third Quarter Results | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/11/05 | 22 : 30 | PR Newswire (US) | Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004 | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/09/27 | 23 : 33 | PR Newswire (US) | Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends Until | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |
| 2004/09/22 | 23 : 03 | PR Newswire (US) | Guilford to Present at UBS Global Life Sciences Conference | NASDAQ:GLFD | Guilford Pharmaceuticals (MM) |